Focus, bold bets, and a bit of fun: How a pharma chief is going for growth
By
Jean-François Manzoni
1d agoen
Source
IMDFocus, bold bets, and a bit of fun: How a pharma chief is going for growthimd.orgIpsen CEO David Loew tells Jean-François Manzoni how relentless focus, the Pareto principle, and having fun helped energize a mid-sized specialty pharma player to take on bigger rivals. The post Focus, bold bets, and a bit of fun: How a pharma chief is going for growth first appeared on IMD business school for management and leadership courses .
You might also wanna read
Philips Research leader advocates for curiosity-driven innovation and rapid experimentation
Betsabeh Madani-Hermann, a leader at Philips Research, presented a philosophy for corporate innovation at the Holst Centre Innovation Day fo
ioplus.nl·12d ago
China's Rise in Global Clinical Trials: Regulatory Reforms and US Competitiveness
Theo Jaffee and Gabriel Dickinson interview Cremieux about China's rapid ascent to global leadership in clinical trial output. The discussio
pca.st·16d ago
China's Rise in Global Clinical Trials: Regulatory Reforms and US Competitiveness
Theo Jaffee and Gabriel Dickinson interview Cremieux about China's rapid ascent to global leadership in clinical trial output. The discussio
pocketcasts.com·15d ago
How AI Will Transform Biopharma: The Sequence of Change Matters
Ben Liu, CEO of Formation Bio, argues that AI will transform the pharmaceutical industry unevenly and sequentially. Some parts of drug disco
a16z.news·17d ago
Ipsen acquires Kartos Therapeutics in $1.75 billion deal
qz.com·8d agoWhy Big Bets Fail: The Case for Small Learnable Chunks in Reform and Product Development
The article explores how both political reforms and product development fail due to excessive decision risk concentrated in single large bet
kasperjunge.com·6d ago
Comments
Sign in to join the conversation.
No comments yet. Be the first.